Consensus and controversy regarding osteoporosis in the pediatric population

Endocrine Practice

Volumn 13, Issue 5, 2007, Pages 513-520

  Bachrach, Laura Keyes ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; CHILD; CONSENSUS; HUMAN; OSTEOPOROSIS; PEDIATRICS; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; STANDARD;

ADOLESCENT; CHILD; CONSENSUS; HUMANS; OSTEOPOROSIS; PEDIATRICS; PRACTICE GUIDELINES; RISK FACTORS;

EID: 35148881181     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.13.5.513     Document Type: Review

References (69)

1. US Department of Health and Human Services. The 2004 Surgeon General's Report on Bone Health and Osteoporosis: What it Means to You. Washington, DC: Office of the Surgeon General, US Department of Health and Human Services, 2004.
2. Bachrach LK. Osteoporosis and measurement of bone mass in children and adolescents. Endocrinol Metab Clin N Amer. 2005;34:521-535.
3. Heaney RP, Abrams S, Dawson-Hughes B, et al. Peak bone mass. Osteoporos Int. 2000;11:985-1009.
4. Hui SL, Slemenda CW, Johnston CC. Age and bone mass as predictors of fracture in a prospective study. J Clin Invest. 1988;81:1804-1809.
5. Liu YJ, Shen H, Xiao P, et al. Molecular genetic studies of gene identification for osteoporosis: a 2004 update. J Bone Miner Res. 2006;21:1511-1535.
6. Vestergaard P, Emborg C, Stoving RK, Hagen C, Mosekilde L, Brixen K. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders - a nationwide register study. Int J Eat Disord. 2002;32:301-308.
7. Miller KK, Lee EE, Lawson EA, et al. Determinants of skeletal loss and recovery in anorexia nervosa. J Clin Endocrinol Metab. 2006;91:2931-2937.
8. Goulding A, Grant AM, Williams SM. Bone and body composition of children and adolescents with repeated forearm fractures. J Bone Miner Res. 2005;20:2090-2096.
9. Henderson RC, Kairalla JA, Barrington JW, Abbas A, Stevenson RD. Longitudinal changes in bone density in children and adolescents with moderate to severe cerebral palsy. J Pediatr. 2005;146:769-775.
10. Larson CM, Henderson RC. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop. 2000;20:71-74.
11. Burnham JM, Shults J, Weinstein R, Lewis JD, Leonard MB. Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database. Ann Rheum Dis 2006;65:1074-1079.
12. Ward LM. Osteoporosis due to glucocorticoid use in children with chronic illness. Horm Res. 2005;64:209-221.
13. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363:1377-1385.
14. Aris RM, Merkel PA, Bachrach LK, et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab. 2005;90:1888-1896.
15. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med. 2004;351:868-875.
16. Burnham JM, Shults J, Semeao E, et al. Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res. 2004;19:1961-1968.
17. van Staa TP, Cooper C, Leufkens HG, Bishop N. Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res. 2003;18:913-918.
18. Bailey DA, Wedge JH, McCulloch RG, Martin AD, Bernhardson SC. Epidemiology of fractures of the distal end of the radius in children as associated with growth. J Bone Joint Surg. 1988;8:1226.
19. Cooper C, Dennison EM, Leufkens HG, Bishop N, van Staa TP. Epidemiology of childhood fractures in Britain: a study using the General Practice Research Database. J Bone Miner Res. 2004;19:1976-1981.
20. Skaggs DL, Loro ML, Pitukcheewanont P, Tolo V, Gilsanz V. Increased body weight and decreased radial cross-sectional dimensions in girls with forearm fractures. J Bone Miner Res. 2001;16:1337-1342.
21. Ferrari SL, Chevalley T, Bonjour JP, Rizzoli R. Childhood fractures are associated with decreased bone mass gain during puberty: an early marker of persistent bone fragility? J Bone Miner Res. 2006;21:501-507.
22. Goulding A, Jones IE, Williams SM, et al. First fracture is associated with increased risk of new fractures during growth. J Pediatr. 2005;146:286-288.
23. National Institutes of Health Consensus Development Panel. Osteoporosis prevention, diagnosis, and therapy. National Institutes of Health Consensus Development Conference Statement. Bethesda, MD: National Institutes of Health, 2000.
24. Landin LA. Fracture patterns in children. Analysis of 8,682 fractures with special reference to incidence, etiology and secular changes in a Swedish urban population 1950-1979. Acta Orthop Scand Suppl. 1983;202:1-109.
25. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. In press.
26. Writing Group for the ISCD Position Development Conference. Diagnosis of osteoporosis in men, premenopausal women, and children. J Clin Densitom. 2004;7:17-26.
27. Miller PD. Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction. Curr Osteoporos Rep. 2005;3:103-110.
28. Bonnick SL, Shulman L. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? Am J Med. 2006;119(4)(Suppl 1):S25-S31.
29. Schonau E, Rauch F. Markers of bone and collagen metabolism-problems and perspectives in paediatrics. Horm Res. 1997;48(Suppl 5):50-59.
30. Mora S, Pitukcheewanont P, Kaufman FR, Nelson JC, Gilsanz V. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development. J Bone Miner Res. 1999;14:1664-1671.
31. Rauchenzauner M, Schmid A, Heinz-Erian P, et al. Sex-and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab. 2007;92:443-449.
32. Specker BL, Schoenau E. Quantitative bone analysis in children: current methods and recommendations. J Pediatr. 2005;146:726-731.
33. Fewtrell MS, Gordon I, Biassoni L, Cole TJ. Dual x-ray absorptiometry (DXA) of the lumbar spine in a clinical paediatric setting: Does the method of size-adjustment matter? Bone. 2005;37:413-419.
34. Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepard JA. The Bone Mineral Density in Childhood Study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab; 2007: 92: 2087-2099.
35. Ward KA, Ashby R, Roberts SA, Adams JE, Zulf Mughal M. UK reference data for the Hologic QDR Discovery dual energy x-ray absorptiometry scanner in healthy children and young adults aged 6-17 years. Arch Dis Child. 2007;92:53-59.
36. Crabtree NJ, Kibirige MS, Fordham JN, et al. The relationship between lean body mass and bone mineral content in paediatric health and disease. Bone. 2004;35:965-972.
37. Horlick M, Wang J, Pierson RN, Thornton JC. Prediction models for evaluation of total-body bone mass with dualenergy x-ray absorptiometry among children and adolescents. Pediatrics. 2004;114:337-345.
38. Zanchetta JR, Plotkin H, Alvarez Filgueira ML. Bone mass in children: normative values for the 2-20-year-old population. Bone. 1995;16(Suppl 4):393S-399S.
39. Leonard MB, Propert KJ, Zemel BS, Stallings VA, Feldman HI. Discrepancies in pediatric bone mineral density reference data; potential for misdiagnosis of osteopenia. J Pediatr. 1999;135:182-188.
40. Wren TA, Liu X, Pitukcheewanont P, Gilsanz V. Bone acquisition in healthy children and adolescents: comparisons of dual-energy x-ray absorptiometry and computed tomography measures. J Clin Endocrinol Metab. 2005;90:1925-1928.
41. Wren TA, Liu X, Pitukcheewanont P, Gilsanz V. Bone densitometry in pediatric populations: discrepancies in the diagnosis of osteoporosis by DXA and CT. J Pediatr. 2005;146:776-779.
42. Jones G, Ma D, Cameron F. Bone density interpretation and relevance in Caucasian children aged 9-17 years of age: insights from a population-based fracture study. J Clin Densitom. 2006;9:202-209.
43. Clark EM, Ness AR, Bishop NJ, Tobias JH. Association between bone mass and fractures in children: a prospective cohort study. J Bone Miner Res. 2006;21:1489-1495.
44. Wosje KS, Specker BL. Role of calcium in bone health during childhood. Nutr Rev. 2000;58:253-268.
45. National Institutes of Health Consensus Development Panel. Optimal calcium intake. JAMA. 1994;272: 1942-1948.
46. . Gartner LM, Greer FR, Section on Breastfeeding and Committee on Nutrition. Prevention of rickets and vitamin D deficiency: New guidelines for vitamin D intake. Pediatrics 2003; 111: 908-910.
47. Hochberg Z, Bereket A, Davenport M, et al. Consensus development for the supplementation of vitamin D in childhood and adolescence. Horm Res. 2002;58:39-51.
48. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004;89:5387-5391.
49. Chad KE, Bailey DA, McKay HA, Zello GA, Snyder RE. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr. 1999;135:115-117.
50. Ward K, Alsop C, Caulton J, Rubin C, Adams J, Mughal Z. Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res. 2004; 19:360-369.
51. Gilsanz V, Wren TA, Sanchez M, Dorey F, Judex S, Rubin C. Low-level, high-frequency mechanical signals enhance musculoskeletal development of young women with low BMD. J Bone Miner Res. 2006;21:1464-1474.
52. MacKelvie KJ, Khan KM, McKay HA. Is there a critical period for bone response to weight-bearing exercise in children and adolescents? A systematic review. Br J Sports Med. 2002;36:250-257.
53. Klein GL, Fitzpatrick LA, Langman CB, et al (ASBMR Group). The state of pediatric bone: summary of the ASBMR Pediatric Bone Initiative. J Bone Miner Res. 2005;20:2075-2081.
54. Klein GL, Bachrach LK, Holm IA. Effects of pharmacologic agents on bone in childhood: an editorial overview. Pediatrics. 2007. 119(Suppl 2):S125-S130.
55. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effect of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab. 1995;80:898-904.
56. Grinspoon S, Thomas L, Miller K, Herzog D, Klibanski A. Effects of recombinant human IGF-1 and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2002;87:2883-2891.
57. Gordon CM, Grace E, Emans SJ, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab. 2002;87:4935-4941.
58. Liu SL, Lebrun CM. Effect of oral contraceptives and hormone replacement therapy on bone mineral density in premenopausal and perimenopausal women: a systematic review. Br J Sports Med. 2006;40:11-24.
59. Gibson JH, Mitchell A, Reeve J, Harries MG. Treatment of reduced bone mineral density in athletic amenorrhea: a pilot study. Osteoporos Int. 1999;10:284-289.
60. Cobb KL, Bachrach LK, Sowers M, et al. Randomized trial of the effect of oral contraceptives on bone mass and stress fractures in female runners. Med Sci Sports Ex. In Press.
61. Glorieux FH. Experience with bisphosphonates in osteogenesis imperfecta. Pediatrics. 2007;119(Suppl 2):S163-S165.
62. Glorieux FH, Rauch F, Ward LM, et al. Alendronate in the treatment of pediatric osteogenesis imperfecta [Abstract]. J Bone Miner Res. 2004;19:S12.
63. Golden NH, Iglesias EA, Jacobson MS, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2005;90:3179-3185.
64. Högler W, Yap F, Little D, Ambler G, McQuade M, Cowell CT. Short-term safety assessment in the use of intravenous zoledronic acid in children. J Pediatr. 2004;145:701-704.
65. Whyte MP, Wendkert D, Clements KL, McAlister WH, Mumm S. Bisphosphonate-induced osteopetrosis. N Engl J Med. 2003;349:457-463.
66. Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH. Osteogenesis imperfecta types I, II, and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab. 2003;88:986-992.
67. Gandrud LM, Cheung JC, Daniels MW, Bachrach LK. Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis. J Pediatr Endocrinol Metab. 2003; 16:887-892.
68. Rauch F, Travers R, Glorieux FH. Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy. J Clin Endocrinol Metab. 2006;91:511-516.
69. Rauch F, Cornibert S, Cheung M, Glorieux FH. Longbones changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta. Bone. 2007; 40:821-827.